// App-Quantinova.ai

10515 : Treatment of childhood adrenocortical carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: Results of the Children's Oncology Group ARAR0332 protocol.

Researchers

Presenter

  • Carlos Rodriguez-Galindo

Principal Investigators

  • Alberto S. Pappo

  • Mark D. Krailo

  • Farzana Pashankar

  • Eliana Maria Monteiro Caran

  • John Hicks

  • Mary B McCarville

  • Christopher Bertero Weldon

  • David Malkin

  • Gerard Zambetti

  • Antonio Conclaves de Oliveira Filho

  • Michael P LaQuaglia

  • Maria Jose Mastellaro

  • Raul Correa Ribeiro

Medical Centers

  • Dana-Farber Cancer Institute, Children's Hospital, Boston, MA

  • St. Jude Children's Research Hospital, Memphis, TN

  • Children's Oncology Group, Monrovia, CA

  • Yale Cancer Center, Yale University, New Haven, CT

  • Instituto de Oncologia Pediatrica/GRAACC/UNIFESP, Sao Paulo, Brazil

  • Baylor College of Medicine, Houston, TX

  • Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA

  • Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

  • St. Jude Children's Research Hospital, Memphis, TN

  • Centro Infantil Boldrini, San Paulo, Brazil

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Department of Post-Graduation in Children and Adolescents Health, University of Campinas, and Department of Pediatric Oncology, Boldrini Children's Center, Sao Paulo, Brazil

Locations

  • United States

  • Canada

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Adrenal carcinoma

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Doxorubicin

  • Etoposide

  • Etoposide phosphate

  • Cisplatin

  • Lysodren

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT00304070

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved